recent publications
-
academic article
- Kaul, P., Newby, L. K., Fu, Y. L., Mark, D. B., Califf, R. M., Topol, E. J., Aylward, P., Granger, C. B., Van de Werf, F., Armstrong, P. W., Grp, Vigour International differences in evolution of early discharge after acute myocardial infarction Lancet 2004 363:511-517 DOI:10.1016/s0140-6736(04)15536-0 PMID:14975612
- Grines, C., Patel, A., Zijlstra, F., Weaver, W. D., Granger, C., Simes, R. J., Ellis, S., Betriu, A., Garcia, E., Grinfeld, L., Gibbons, R., Ribeiro, E., et al. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: Six-month follow up and analysis of individual patient data from randomized trials American Heart Journal 2003 145:47-57 DOI:10.1067/mhj.2003.40 PMID:12514654
- Topol, E. J., Califf, R. M., Van de Werf, F., Willerson, J. T., Booth, J., White, H., Clayman, M., Deckelbaum, L., Lincoff, A. M., Ohman, E. M., Bates, E., Gibler, W. B., et al. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein iib/iiia inhibition: The gusto randomised trial Lancet 2001 357:1905-1914 PMID:11425410
- Topol, E. J., Ohman, E. M., Armstrong, P. W., Wilcox, R., Skene, A. M., Aylward, P., Simes, J., Dalby, A., Betriu, A., Bode, C., White, H. D., Hochman, J. S., et al. Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction - results from the global utilization of streptokinase and t-pa for occluded coronary arteries (gusto) iii trial Circulation 2000 102:1761-1765 PMID:11023929
- Topol, C. E., Califf, R. M., Simes, R. J., Van de Werf, F., Diaz, R., Paolasso, E., Aylward, P. E., Keech, A., Klein, W., Piegas, L., Tomov, I., Armstrong, P. W., et al. Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: A randomised trial Lancet 2000 355:337-345 PMID:10665552
- Van de Werf, F., Adgey, J., Ardissino, D., Armstrong, P. W., Aylward, P., Barbash, G., Betriu, A., Binbrek, A. S., Califf, R., Diaz, R., Fanebust, R., Fox, K., et al. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The assent-2 double-blind randomised trial Lancet 1999 354:716-722 DOI:10.1016/s0140-6736(99)07403-6 PMID:10475182
- Hochman, J. S., Tamis, J. E., Thompson, T. D., Weaver, W. D., White, H. D., Van de Werf, F., Aylward, P., Topol, E. J., Califf, R. M., Global Use Strategies Open Occluded Coronary, Ar Sex, clinical presentation, and outcome in patients with acute coronary syndromes New England Journal of Medicine 1999 341:226-232 DOI:10.1056/nejm199907223410402 PMID:10413734
- Topol, E., Califf, R., Ohman, E., Wilcox, R., Grinfeld, L., Aylward, P., Simes, R., Probst, P., vandeWerf, F., Armstrong, P., Heikkila, J., Vahanian, A., et al. A comparison of reteplase with alteplase for acute myocardial infarction New England Journal of Medicine 1997 337:1118-1123 PMID:9340503
- Betriu, A., Phillips, H., Ellis, S., Topol, E., Califf, R., VanderWerf, F., Ardissino, D., Armstrong, P. W., Aylward, P., Bates, E., Beatt, K., Cheseboro, J., et al. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction New England Journal of Medicine 1997 336:1621-1628 PMID:9173270
- Topol, E. J., Califf, R., Granger, C., VandeWerf, F., Aylward, P., Simes, J., Col, J., Armstrong, P., Vahanian, A., Neuhaus, K., Rutsch, W., Ardissino, D., et al. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes New England Journal of Medicine 1996 335:775-782 DOI:10.1056/NEJM199609123351103 PMID:8778585
- Barbash, G. I., Reiner, J., White, H. D., Wilcox, R. G., Armstrong, P. W., Sadowski, Z., Morris, D., Aylward, P., Woodlief, L. H., Topol, E. J., Califf, R. M., Ross, A. M. Evaluation of paradoxic beneficial-effects of smoking in patients receiving thrombolytic therapy for acute myocardial-infarction - mechanism of the smokers paradox from the gusto-i trial, with angiographic insights Journal of the American College of Cardiology 1995 26:1222-1229 DOI:10.1016/0735-1097(95)00299-5 PMID:7594035
- Lee, K. L., Woodlief, L. H., Topol, E. J., Weaver, W. D., Betriu, A., Col, J., Simoons, M., Aylward, P., Vandewerf, F., Califf, R. M. Predictors of 30-day mortality in the era of reperfusion for acute myocardial-infarction - results from an international trial of 41 021 patients Circulation 1995 91:1659-1668 PMID:7882472
- Topol, E., Califf, R., Vandewerf, F., Ardissino, D., Armstrong, P., Aylward, P., Barbash, G., Bates, E., Beatt, K., Betriu, A., Chesebro, J., Col, J., et al. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes Circulation 1994 90:1631-1637 PMID:7923645
- Ross, A. M., Simoons, M. L., Lundergan, C., Thompson, M., Reiner, J., Deychak, Y., Rohrbeck, S., Coyne, K., Walker, P., Cho, S., Greenhouse, S., Lee, K., et al. The effects of tissue-plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular-function, and survival after acute myocardial-infarction New England Journal of Medicine 1993 329:1615-1622 PMID:8232430
- Hampton, J., Wilcox, R., Armstrong, P., Aylward, P., Bett, N., Charbonnier, B., Gulba, D., Heikkila, J., Jensen, G., Lopezbescos, L., Moulopoulos, S., Seabragomes, R., et al. Late assessment of thrombolytic efficacy (late) study with alteplase 6-24 hours after onset of acute myocardial-infarction Lancet 1993 342:759-766 PMID:8103874
- Topol, E., Califf, R., Vandewerf, F., Armstrong, P. W., Aylward, P., Barbash, G., Bates, E., Betriu, A., Boissel, J. P., Chesebro, J., Col, J., Debono, D., et al. An international randomized trial comparing 4 thrombolytic strategies for acute myocardial-infarction New England Journal of Medicine 1993 329:673-682 PMID:8204123